Skip to main navigation

Main navigation

  • Company
    • Overview
    • Management
    • Board of Directors
    • Advisory Board
    • Compliance and Ethics
    • We Care
  • Metabolic Acidosis & CKD
    • About Metabolic Acidosis
    • About CKD
    • Visual Abstracts
    • Medical Information
  • Veverimer
    • About Veverimer
    • Expanded Access
  • News
  • Investors
    • Overview
    • Presentations & Events
    • SEC Filings
    • Governance
    • Annual Report & Proxy
    • Stock
    • Analyst Coverage
    • Contact IR
  • Careers
    • Life at Tricida
    • Benefits
    • Job Opportunities
  • Contact

SEC Filing Details

Investor Relations

  • Overview
  • Presentations & Events
  • SEC Filings
  • Governance
    • Governance Documents
    • Committee Composition
    • Board of Directors
    • Management Team
  • Annual Report & Proxy
  • Stock
  • Analyst Coverage
  • Contact IR
    • Information Request
    • Email Alerts
    • FAQs
    • IR Site Map
SEC Filing Details

SEC Filing Details

Document Details

Form
8-K
Filing Date
Dec 22, 2022
Document Date
Dec 19, 2022
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Tricida, Inc.
Issuer
Tricida, Inc.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
XML - XBRL INSTANCE DOCUMENT

Footer Policy Links

  • Privacy Policy
  • Terms
  • Forward Looking Statement
  • Site Map

Main navigation

  • Company
  • Metabolic Acidosis & CKD
  • Veverimer
  • News
  • Investors
  • Careers
  • Contact
HEADQUARTERS
Tricida Inc.
7000 Shoreline Court, Suite 201
South San Francisco, CA 94080
(415) 429-7800

Footer Social Link

©2023 Tricida, Inc. All rights reserved.